Sold as Biphetamine 20, Biphetamine 12.5, Biphetamine 7.5. Every FDA application for this active ingredient.
As of Nov 16, 2026, FDA lists 1 application for Amphetamine Resin Complex; Dextroamphetamine Resin Complex (sold as Biphetamine 20, Biphetamine 12.5, Biphetamine 7.5), first approved Sep 9, 1955, with 0 new uses approved and 0 published complete response letters.
| Approved | Application | Sponsor | Supplements | Marketing |
|---|---|---|---|---|
| Sep 9, 1955 | Biphetamine 20, Biphetamine 12.5NDA 10093 ยท New active ingredient | Ucb Inc | 3 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA